Arsene Mekinian/X
Dec 24, 2025, 05:57
Arsene Mekinian Shares a Concise Update: The Evolving Understanding of PR PID
Arsene Mekinian, Professor of Medicine at Sorbonne University, President of Santé Arménie, posted on LinkedIn:
“PR PID
No unequivocal definition but any manifestation, including asymptomatic pulmonary
Significant mortality
No screening except for clinical signs
Genetic marker MUC5B
Dogma not TNFi would be invalidated by a recent study”
Follow the latest in Hemostasis Today.
-
Apr 22, 2026, 06:01Kathaleen Schnur: Global Perspectives on Psychosocial Support in Hemophilia Care
-
Apr 22, 2026, 05:43Maia Meier: A Journey to Raise Awareness for Women with Bleeding Disorders
-
Apr 22, 2026, 05:41Moustafa Abdou: Diagnostic Challenges in Pediatric Hematology
-
Apr 22, 2026, 04:43Ifeanyichukwu Ifechidere: The Critical Role of Calibrator Specificity in Anticoagulation Monitoring
-
Apr 22, 2026, 04:13Ilenia Calcaterra: Clinical Relevance of Persistent Pain in Emicizumab-Treated Haemophilia A
-
Apr 22, 2026, 03:56Annette Bowyer: Reflecting on Progress and Leadership in Laboratory Sciences
-
Apr 21, 2026, 21:07Tareq Abadl: Not Every Low Platelet Count Is True – Check the Smear First
-
Apr 21, 2026, 21:05Beverley Hunt: Honored to Receive the Lifetime Achievement Award at BSH 2026
-
Apr 21, 2026, 21:03Toong Youttananukorn: Proud to Support Data That Drives Action at WFH 2026